Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alecensa
2. Alectinib
3. Ch5424802
4. Ro5424802
1. 1256589-74-8
2. Af-802 Hydrochloride
3. Alectinib Hcl
4. Alecensa
5. P9yy73lo6j
6. Alectinib Hydrochloride (jan)
7. Alectinib (hydrochloride)
8. Ch5424802 (hydrochloride)
9. Schembl14991271
10. 5h-benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-, Hydrochloride (1:1)
11. Alectinib Hydrochloride [jan]
12. 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5h-benzo[b]carbazole-3-carbonitrile Hydrochloride
13. Unii-p9yy73lo6j
14. Alecensa (tn)
15. 5h-benzo(b)carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-, Hydrochloride (1:1)
16. Alectinib Monohydrochloride
17. Af-802 (hydrochloride)
18. Agn-pc-09o9bf
19. Ro5424802 (hydrochloride)
20. Chembl3707320
21. Chebi:62268
22. Ch5424802 Hcl
23. Dtxsid10154841
24. Ch 5424802, Alectinib Hcl
25. Bcp09075
26. Ex-a1553
27. Alectinib Hydrochloride [mi]
28. Ch-5424802 Hydrochloride
29. Hy-13011a
30. Mfcd27987893
31. S5232
32. Ccg-264759
33. Cs-3480
34. Sb16516
35. Alectinib Hydrochloride [who-dd]
36. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazole-3-carbonitrile,hydrochloride
37. Ac-29721
38. As-17062
39. Alectinib Hydrochloride [orange Book]
40. D10450
41. Q27104897
42. Ch5424802 Hcl Salt, Alectinib Hcl Salt, Af802 Hcl Salt
43. Ch-5428402 Hcl; Af-802 Hydrochloride; Rg-7853 Hydrochloride; Ro-5424802 Hydrochloride
44. 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5h-benzo[b]carbazole-3-carbonitrile Hydrochloride (1:1)
45. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5h-benzo[b]carbazole-3-carbonitrile Monohydrochloride Salt
46. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazole-3-carbonitrile;hydrochloride
47. Alectinib Hydrochloride;af-802 Hydrochloride;ch-5424802 Hydrochloride;rg-7853 Hydrochloride;ro-5424802 Hydrochloride
1. Alectinib
2. 1256580-46-7
3. Arq-761
4. Cas 1416163-60-4
5. Cas 1256580-46-7
Molecular Weight | 519.1 g/mol |
---|---|
Molecular Formula | C30H35ClN4O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 518.2448541 g/mol |
Monoisotopic Mass | 518.2448541 g/mol |
Topological Polar Surface Area | 72.4 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 867 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Alecensa as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
Alecensa as monotherapy is indicated for the treatment of adult patients with ALKpositive advanced NSCLC previously treated with crizotinib.
L01ED03
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
74
PharmaCompass offers a list of Alectinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alectinib Hydrochloride manufacturer or Alectinib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alectinib Hydrochloride manufacturer or Alectinib Hydrochloride supplier.
PharmaCompass also assists you with knowing the Alectinib Hydrochloride API Price utilized in the formulation of products. Alectinib Hydrochloride API Price is not always fixed or binding as the Alectinib Hydrochloride Price is obtained through a variety of data sources. The Alectinib Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alectinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alectinib Hydrochloride, including repackagers and relabelers. The FDA regulates Alectinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alectinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alectinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alectinib Hydrochloride supplier is an individual or a company that provides Alectinib Hydrochloride active pharmaceutical ingredient (API) or Alectinib Hydrochloride finished formulations upon request. The Alectinib Hydrochloride suppliers may include Alectinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Alectinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alectinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Alectinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Alectinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Alectinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alectinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Alectinib Hydrochloride USDMF includes data on Alectinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alectinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alectinib Hydrochloride suppliers with USDMF on PharmaCompass.
A Alectinib Hydrochloride written confirmation (Alectinib Hydrochloride WC) is an official document issued by a regulatory agency to a Alectinib Hydrochloride manufacturer, verifying that the manufacturing facility of a Alectinib Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alectinib Hydrochloride APIs or Alectinib Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Alectinib Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Alectinib Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alectinib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alectinib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alectinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alectinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alectinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alectinib Hydrochloride suppliers with NDC on PharmaCompass.
Alectinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alectinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alectinib Hydrochloride GMP manufacturer or Alectinib Hydrochloride GMP API supplier for your needs.
A Alectinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Alectinib Hydrochloride's compliance with Alectinib Hydrochloride specifications and serves as a tool for batch-level quality control.
Alectinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Alectinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alectinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Alectinib Hydrochloride EP), Alectinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alectinib Hydrochloride USP).